But if it’s good to ask that question about a medical procedure, isn’t it equally good to ask the same question about the entire Obamacare program? When we do it turns out that Obamacare fails the test.
To a lot of Americans, comparing health care outcomes with their money cost is an abhorrent idea.
But in his book Critical: What We Can Do About the Health-Care Crisis, Tom Daschle, President Obama’s first choice to head the Department of Health and Human Resources, said that such health care rationing is essential if we are to control costs. Daschle pointed to Britain as a country that routinely does what he had in mind.
According to a 2002 World Health Organization report, 25,000 cancer patients die prematurely in Britain each year -- often because of lack of access to drugs generally available in the United States and Europe. (See also this 2013 NHS estimate on all causes of premature deaths.)
So how do the British determine who gets what in their health system? As Aaron Carrol writes:
Other countries routinely use cost-effectiveness data to make decisions about health coverage. In Britain, the National Institute for Health and Care Excellence, a government agency that gives guidance about which services the National Health Service should cover, has a threshold of 20,000 to 30,000 pounds per QALY (about $31,000 to $47,000).
They don’t make decisions on whether to cover therapies based on this number alone, but it is certainly considered a factor.

